All levels of the growth hormone (GH), GH binding protein (GHBP), insu
lin-like growth factor (IGF) and IGF binding protein (IGFBP) axis are
influenced by chronic hypercortisolism. Thus, there is a blunted respo
nse to GHRH alone or together with other stimuli associated with a mar
ked suppression of endogenous GH secretion but accompanied by normal G
HBP, normal to low IGF-1 and GHBPs 1 and 3 with the correspondent 41.5
and 38.5-kD molecular forms of the latter presenting values similar t
o normal. These findings may suggest enhanced GH sensitivity with norm
al or increased IGF-1 bioavailability to the correspondent tissue rece
ptors. In conclusion, the glucocorticoid (GC)-induced target tissue re
sistance can neither be attributed to the suppression of the GH axis n
or to changes in circulating GHBPs 1 and 3. However, it may be related
either to the described 12- to-20-kD inhibitor(s) which antagonizes p
ostbinding IGF-1 bioactivity (gene expression) and/or by the downmodul
ation of activator protein-1 (Fos/Jun) activity by the GC-GC receptor
complex.